Skip to main content

Table 2 Correlation analyses of variables associated with Lp-PLA2 activity

From: Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study

 

r

P value

Age(yr)

-0.058

0.273

Male

0.020

0.700

Body mass index(kg/m2)

0.088

0.097

Smoking history

0.067

0.204

Hypertension

0.017

0.747

Diabetes

-0.013

0.810

Statin

-.146

0.005

Hemoglobin(g/L)

0.032

0.549

Albumin(g/L)

-0.002

0.966

Urea (mmol/L)

0.007

0.898

Serum creatinine(μmol/L)

0.087

0.099

Uric acid (mmol/L)

-0.012

0.827

Total cholesterol (mmol/L)

.463

 < 0.001

LDL-c (mmol/L)

.443

 < 0.001

HDL-c (mmol/L)

-0.033

0.526

Apo-B (g/L)

.445

 < 0.001

Apo-A (g/L)

-0.030

0.571

Triglyceride (mmol/L)

.149

0.004

Lp(a) (nmol/L)

0.021

0.693

hs-CRP (mg/L)

0.025

0.642

  1. Apo Apolipoprotein, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, Lp Lipoprotein, hs-CRP High-sensitivity C-reactive protein